Animal Study Suggests Ritalin Won't Harm the Heart
Title: Animal Study Suggests Ritalin Won't Harm the HeartCategory: Health NewsCreated: 1/9/2019 12:00:00 AMLast Editorial Review: 1/10/2019 12:00:00 AM (Source: MedicineNet Kids Health General)
Source: MedicineNet Kids Health General - January 10, 2019 Category: Pediatrics Source Type: news
Animal Study Suggests Ritalin Won't Harm the Heart
WEDNESDAY, Jan. 9, 2019 -- Ritalin, a widely used stimulant drug to treat attention-deficit/hyperactivity disorder (ADHD), likely poses no risk of heart damage in children, new research in monkeys suggests.
The findings are " very reassuring, " said... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 9, 2019 Category: General Medicine Source Type: news
Ritalin drives greater connection between brain areas key to memory, attention
(University of Wisconsin-Madison) Louis Populin and collaborators at the University of Wisconsin-Madison collaborators published a study this week in the Journal of Neuroscience describing increased connections between key parts of the brains of monkeys who have taken methylphenidate (Ritalin). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 12, 2018 Category: International Medicine & Public Health Source Type: news
Possible Tie to First-Line ADHD Drug and Psychotic Symptoms Possible Tie to First-Line ADHD Drug and Psychotic Symptoms
Noting the quality of the data may be questionable, researchers are warning clinicians about the possibility that methylphenidate may carry a risk for hallucinations and other psychotic symptoms in kids.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 30, 2018 Category: Consumer Health News Tags: Psychiatry News Source Type: news
One of the most popular ADHD drugs may cause hallucinations and other psychotic symptoms
(Exeley Inc.) One of the most popular ADHD drugs may cause hallucinations and other psychotic symptoms. Research published in the SJCAPP says that possible adverse symptoms may affect 1.1 percent -- 2.5 percent of ADHD patients treated with methylphenidate. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 22, 2018 Category: International Medicine & Public Health Source Type: news
Jornay PM (Methylphenidate Hydrochloride Extended-release Capsules ) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - August 17, 2018 Category: Drugs & Pharmacology Source Type: news
Methylphenidate Good First - Choice Pediatric ADHD Drug
For adults, amphetamines are reasonable first choice to treat attention - deficit hyperactivity disorder (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - August 17, 2018 Category: Psychiatry Tags: Family Medicine, Internal Medicine, Neurology, Nursing, Pediatrics, Pharmacy, Psychiatry, Journal, Source Type: news
Methylphenidate Good First-Choice Pediatric ADHD Drug
THURSDAY, Aug. 16, 2018 -- Methylphenidate should be considered as a first choice for the treatment of attention-deficit hyperactivity disorder (ADHD) in children and adolescents, while amphetamines should be considered as a first choice in adults,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 16, 2018 Category: Pharmaceuticals Source Type: news
FDA Clears First ADHD Bedtime Medication FDA Clears First ADHD Bedtime Medication
Jornay PM is a novel formulation of methylphenidate taken in the evening instead of first thing in the morning to provide early-morning control of attention-deficit/hyperactivity disorder (ADHD) symptoms.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 10, 2018 Category: Consumer Health News Tags: Psychiatry News Source Type: news
Methylphenidate Best First-Line Drug Choice for ADHD in Kids Methylphenidate Best First-Line Drug Choice for ADHD in Kids
Methylphenidate appears to be the best first-line drug choice for attention- deficit/hyperactivity disorder (ADHD) in children and adolescents, new research shows.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 10, 2018 Category: Consumer Health News Tags: Psychiatry News Source Type: news
FDA Approves Jornay PM (methylphenidate) Extended-Release Capsules for Attention Deficit Hyperactivity Disorder (ADHD)
GEORGE TOWN, Cayman Islands--(BUSINESS WIRE)August 09, 2018 --Ironshore Pharmaceuticals& Development, Inc. ( “Ironshore”) a wholly owned subsidiary of Highland Therapeutics Inc. (“Highland”) announced today that the U.S. Food and Drug... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - August 9, 2018 Category: Drugs & Pharmacology Source Type: news
Which Drugs Work Best for ADHD? Large Study Zeroes in on Two
The researchers compared seven ADHD drugs -- amphetamines (including lisdexamfetamine), atomoxetine, bupropion, clonidine, guanfacine, methylphenidate and modafinil -- and a placebo over 12 weeks of treatment. (Source: WebMD Health)
Source: WebMD Health - August 8, 2018 Category: Consumer Health News Source Type: news
ADHD experts say more children with condition should be given drugs
An NHS-funded study has found that Ritalin is still the best medical option for children with ADHD – reducing symptoms by 78 per cent. Only 0.5 per cent of under-16s in the UK receive the drugs currently. (Source: the Mail online | Health)
Source: the Mail online | Health - August 8, 2018 Category: Consumer Health News Source Type: news
Which Drugs Work Best for ADHD? Large Study Zeroes in on Two
WEDNESDAY, Aug. 8, 2018 -- Researchers have identified what they describe as the safest, most effective short-term drug treatments for attention deficit/hyperactivity disorder (ADHD).
It ' s methylphenidate for kids and amphetamines for adults,... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 8, 2018 Category: General Medicine Source Type: news
Ritalin-type drugs best to treat ADHD in children, shows study
Methylphenidate drugs safest and most effective while adults do better on amphetaminesRitalin and other drugs of the same class are the most effective and safest medications to prescribe for children with attention deficit hyperactivity disorder (ADHD), according to a major scientific review.The review of ADHD drugs shows that they work, and work well, in spite of concerns among the public and some doctors that children in the UK are being overmedicated. Ofsted ’s chief inspector, Amanda Spielman, has likened the drugs to a “chemical cosh” and claimed they were being overprescribed, disguising bad behaviour among chi...
Source: Guardian Unlimited Science - August 8, 2018 Category: Science Authors: Sarah Boseley Health editor Tags: Attention deficit hyperactivity disorder Mental health UK news Source Type: news
